Sharps Technology Expands with European Sales Agreements

Don't Miss our Black Friday Offers:

Sharps Technology, Inc. ( (STSS) ) has issued an update.

Sharps Technology, Inc. has struck significant sales agreements with a major European healthcare network to deliver its SecureGard safety syringes, marking a pivotal expansion in Central and Eastern Europe. The company plans to fulfill all current inventory demands by early 2025 and aims to boost its manufacturing capacity to meet rising demand for its innovative syringe solutions. This move positions Sharps to capitalize on the growing demand for injectable therapies while enhancing their manufacturing capabilities in Hungary.

Find detailed analytics on STSS stock on TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.